A Study Comparing Two Doses of AGTC-501 in Male Subjects With X-linked Retinitis Pigmentosa Caused by RPGR Mutations (SKYLINE)

计划入组 14 人 · 首次发布于 2024 年 3 月 27 日

Activation of miRNA and Proteins After Acute Experimental Pain. (miRNA: Micro RNA)

计划入组 20 人 · 首次发布于 2020 年 6 月 19 日

Effect of Short-term Motor Training on Accuracy and Precision of Knee Movement in Human With and Without Knee Pain

计划入组 60 人 · 首次发布于 2019 年 10 月 31 日

Acyline

C₈₀H₁₀₂ClN₁₅O₁₄

KYLANE LABORATOIRES SA

Switzerland

Nathan S. Kline Institute for Psychiatric Research

United States

FDA Grants Orphan Drug Designation to Skyline Therapeutics' SKG1108 for Retinitis Pigmentosa

Skyline Therapeutics to Present Novel Optogenetic Gene Therapy for Retinitis Pigmentosa at ASGCT 2025

Roche Launches SKYLINE: Four-Year Prevention Trial for Gantenerumab in Early-Stage Alzheimer's